Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proactive Protection With Azithromycin and Hydroxychloroquine in Hospitalized Patients With COVID: A Randomized, Placebo-controlled Double-blinded Trial Evaluating Treatment With Azithromycin and Hydroxychloroquine to Patients With COVID-19

NCT04322396 is registered in ClinicalTrials.gov with Chronic Obstructive Pulmonary Disease Trial Network, Denmark as lead sponsor.

NCT NCT04322396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04322396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proactive Protection With Azithromycin and Hydroxychloroquine in Hospitalized Patients With COVID: A Randomized, Placebo-controlled Double-blinded Trial Evaluating Treatment With Azithromycin and Hydroxychloroquine to Patients With COVID-19
Lead sponsor
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Phase
Phase 2
Overall status
Terminated
Start date
April 6, 2020
Completion date
February 2, 2021
Enrollment
117 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

corona virus infection, infection viral, virus diseases